CLS Form 4: Director Maletira Amar granted 289 share units on 09/30/2025

Rhea-AI Filing Summary

Maletira Amar, a director of Celestica Inc. (CLS), acquired 289 director share units on 09/30/2025. Each unit is a contingent right to receive one common share or cash equivalent when the holder ceases to serve the issuer as a director, consultant, or service provider. The reported transaction shows 755 common shares beneficially owned following the award. The units carry no purchase price ($0) and were reported on Form 4 with a signature executed by an attorney-in-fact on 10/01/2025.

Insights

Financial Analyst

TL;DR: Routine director compensation granted as share units increases insider alignment without immediate cash outlay.

The 289 director share units are a grant of contingent equity compensation rather than an open-market purchase. Such grants are common for non-employee directors and align their economic interests with shareholders upon vesting or termination-triggered settlement. The units have a $0 acquisition price and convert to common shares or cash at Celestica's discretion when the director leaves service, so there is no immediate dilution or cash transfer recorded on the Form 4. The reporting of 755 shares beneficially owned provides context on the director's current direct stake.

Corporate Governance Expert

TL;DR: Standard board compensation disclosed; materiality is low and disclosure is clear.

This Form 4 documents a standard grant of director share units that vest/settle upon cessation of service, consistent with common board pay practices. The filing clearly states the contingent nature of the units and the conversion mechanics. From a governance perspective, the grant increases long-term alignment incentives for the director, and the disclosure meets Section 16 reporting requirements. There are no indications of unusual terms or immediate exercises in the filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Maletira Amar

(Last) (First) (Middle)

5140 YONGE STREET

SUITE 1900

(Street)

TORONTO A6 M2N 6L7

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CELESTICA INC [ CLS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Share Units	(1)	09/30/2025		A		289		(1)	(1)	Common Shares	289	$0	755	D

Explanation of Responses:

1. Each director share unit represents a contingent right to receive one common share or an equivalent value in cash at the Issuer's discretion when the holder ceases to serve the Issuer as any of a director, consultant or other service provider.

	/s/ Tracy Connelly McGilley, attorney-in-fact	10/01/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Maletira Amar report on the Form 4 for CLS?

The Form 4 reports acquisition of 289 director share units on 09/30/2025 and shows 755 common shares beneficially owned following the transaction.

What are director share units as disclosed in this filing?

Each director share unit represents a contingent right to receive one common share or an equivalent cash value when the holder ceases to serve the issuer.

Was there any purchase price for the awarded units?

No. The units are reported with a $0 price on the Form 4, indicating they were granted rather than bought.

When was the Form 4 signed and filed?

The filing shows a signature by an attorney-in-fact dated 10/01/2025 and the transaction date of 09/30/2025.

Does this Form 4 show exercisable options or immediate share transfers?

No. The Form 4 records contingent director share units that convert upon cessation of service; it does not show immediate exercise or share transfers.